Metabolic syndrome and psoriasis: a study in 97 patients

SUMMARY BACKGROUND: Psoriasis is associated with higher prevalence of metabolic syndrome (MS). The prevalence of MS varies according to the studied population as it suffers influence of genetics, aging, sedentary behaviour and diet. OBJECTIVE: To study the prevalence of MS in local psoriasis patie...

Full description

Bibliographic Details
Main Authors: Lana Bassi Ferdinando, Paula Kaori Fukumoto, Sarah Sanches, Lincoln Helder Zambaldi Fabricio, Thelma L Skare
Format: Article
Language:English
Published: Associação Médica Brasileira
Series:Revista da Associação Médica Brasileira
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302018000400368&lng=en&tlng=en
id doaj-83c14aec0d724bbd80f85e31dd20890f
record_format Article
spelling doaj-83c14aec0d724bbd80f85e31dd20890f2020-11-24T23:56:30ZengAssociação Médica BrasileiraRevista da Associação Médica Brasileira1806-928264436837310.1590/1806-9282.64.04.368S0104-42302018000400368Metabolic syndrome and psoriasis: a study in 97 patientsLana Bassi FerdinandoPaula Kaori FukumotoSarah SanchesLincoln Helder Zambaldi FabricioThelma L SkareSUMMARY BACKGROUND: Psoriasis is associated with higher prevalence of metabolic syndrome (MS). The prevalence of MS varies according to the studied population as it suffers influence of genetics, aging, sedentary behaviour and diet. OBJECTIVE: To study the prevalence of MS in local psoriasis patients and the influence of psoriasis variables on its appearance. METHODS: A group of 97 psoriasis patients were studied for MS and compared with 97 controls. Psoriasis type, nail involvement, psoriasis extension measured by PASI (Psoriasis Area and Severity Index) were obtained through physical examination and history of previous myocardial infarction, angina and stroke were obtained through chart review. RESULTS: Comparison of MS prevalence in psoriasis patients (49.4%) with controls (35.0%) showed difference with p=0.04; OR=1.8 (95%CI=1.02-3.23). Patients with psoriasis had higher body mass index (p=0.02), higher systolic blood pressure (p=0.007), lower HDL cholesterol (p=0.01), higher glucose (p=0.04), higher waist circumference (p=0.003) and more angina pectoris (p=0.03;OR=2.5; 95% 0=1.04-6.15) than controls. When psoriasis sample with and without MS were compared, those with MS were older (p=0.0004), had disease onset at older age (p=0.02), more tobacco exposure (p=0.02), and a tendency to have less scalp involvement (p=0.06) in univariate analysis. Logistic regression showed that only age and scalp involvement were independently associated with MS in the psoriasis sample. CONCLUSION: In our psoriasis sample, MS prevalence is high and the items that deserve more attention are central obesity, low HDL, hypertension and smoking habits. In the psoriasis group, MS was associated independently with older age and less scalp involvement.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302018000400368&lng=en&tlng=enPsoríaseSíndrome metabólicaDoenças metabólicas
collection DOAJ
language English
format Article
sources DOAJ
author Lana Bassi Ferdinando
Paula Kaori Fukumoto
Sarah Sanches
Lincoln Helder Zambaldi Fabricio
Thelma L Skare
spellingShingle Lana Bassi Ferdinando
Paula Kaori Fukumoto
Sarah Sanches
Lincoln Helder Zambaldi Fabricio
Thelma L Skare
Metabolic syndrome and psoriasis: a study in 97 patients
Revista da Associação Médica Brasileira
Psoríase
Síndrome metabólica
Doenças metabólicas
author_facet Lana Bassi Ferdinando
Paula Kaori Fukumoto
Sarah Sanches
Lincoln Helder Zambaldi Fabricio
Thelma L Skare
author_sort Lana Bassi Ferdinando
title Metabolic syndrome and psoriasis: a study in 97 patients
title_short Metabolic syndrome and psoriasis: a study in 97 patients
title_full Metabolic syndrome and psoriasis: a study in 97 patients
title_fullStr Metabolic syndrome and psoriasis: a study in 97 patients
title_full_unstemmed Metabolic syndrome and psoriasis: a study in 97 patients
title_sort metabolic syndrome and psoriasis: a study in 97 patients
publisher Associação Médica Brasileira
series Revista da Associação Médica Brasileira
issn 1806-9282
description SUMMARY BACKGROUND: Psoriasis is associated with higher prevalence of metabolic syndrome (MS). The prevalence of MS varies according to the studied population as it suffers influence of genetics, aging, sedentary behaviour and diet. OBJECTIVE: To study the prevalence of MS in local psoriasis patients and the influence of psoriasis variables on its appearance. METHODS: A group of 97 psoriasis patients were studied for MS and compared with 97 controls. Psoriasis type, nail involvement, psoriasis extension measured by PASI (Psoriasis Area and Severity Index) were obtained through physical examination and history of previous myocardial infarction, angina and stroke were obtained through chart review. RESULTS: Comparison of MS prevalence in psoriasis patients (49.4%) with controls (35.0%) showed difference with p=0.04; OR=1.8 (95%CI=1.02-3.23). Patients with psoriasis had higher body mass index (p=0.02), higher systolic blood pressure (p=0.007), lower HDL cholesterol (p=0.01), higher glucose (p=0.04), higher waist circumference (p=0.003) and more angina pectoris (p=0.03;OR=2.5; 95% 0=1.04-6.15) than controls. When psoriasis sample with and without MS were compared, those with MS were older (p=0.0004), had disease onset at older age (p=0.02), more tobacco exposure (p=0.02), and a tendency to have less scalp involvement (p=0.06) in univariate analysis. Logistic regression showed that only age and scalp involvement were independently associated with MS in the psoriasis sample. CONCLUSION: In our psoriasis sample, MS prevalence is high and the items that deserve more attention are central obesity, low HDL, hypertension and smoking habits. In the psoriasis group, MS was associated independently with older age and less scalp involvement.
topic Psoríase
Síndrome metabólica
Doenças metabólicas
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302018000400368&lng=en&tlng=en
work_keys_str_mv AT lanabassiferdinando metabolicsyndromeandpsoriasisastudyin97patients
AT paulakaorifukumoto metabolicsyndromeandpsoriasisastudyin97patients
AT sarahsanches metabolicsyndromeandpsoriasisastudyin97patients
AT lincolnhelderzambaldifabricio metabolicsyndromeandpsoriasisastudyin97patients
AT thelmalskare metabolicsyndromeandpsoriasisastudyin97patients
_version_ 1725458235475886080